¿Hay alguna actualización del TCMH para la terapia con células madre??
Trasplante de células madre hematopoyéticas (TCMH) es un tratamiento de quimioterapia intenso para la EM. Su objetivo es detener el daño que causa la EM al eliminar y luego hacer crecer su sistema inmunológico., using your stem cells.
TCMH (Trasplante de células madre hematopoyéticas) attempts to “reboot” the immune system, which is responsible for damaging the brain and spinal cord in MS. In HSCT for MS, hematopoyético (blood cell-producing) Células madre, which are derived from a person’s own (scientifically referred to as “autologous”) bone marrow or blood, are collected and stored, prior to depleting much of the immune system using chemotherapy drugs. Then the stored hematopoietic stem cells are reintroduced to the body. The new stem cells migrate to the bone marrow and over time reconstitute the immune system.
